Akoya Biosciences, Inc.
AKYADelisted Jul 8, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001711933
Akoya Biosciences, Inc. was delisted on Jul 8, 2025; its insiders filed their last Form 4 on Jul 10, 2025; 58 institutions reported holding it in 13F filings for Q2 2025, worth $16.3M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Akoya Biosciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 59 | 1 | 59 | +1 |
| Shares | 12.4M | 1.50M | 12.1M | +1.21M (+11.1%) |
| Value | $29.0M | $3.51M | $32.9M | +$7.42M (+29.1%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Akoya Biosciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,580,164 | $4.30M | 0.00% |
| Transcend Wealth Collective, LLC | 27,600 | $75.1K | 0.01% |
| ExodusPoint Capital Management, LP | 14,491 | $39.0K | 0.00% |
| Susquehanna International Group, LLP | 13,503 | $36.7K | 0.00% |
| Two Sigma Securities, LLC | 11,087 | $30.2K | 0.00% |
| Capital Performance Advisors LLP | 142 | $386 | 0.00% |
| Ronald Blue Trust, Inc. | 83 | $194 | 0.00% |
| Sterling Capital Management LLC | 26 | $71 | 0.00% |
Sold out (7)
Institutions that held Akoya Biosciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Boston Private Wealth LLC | 515,317 | $1.21M |
| Polar Capital Holdings Plc | 329,756 | $771.6K |
| Squarepoint Ops LLC | 65,949 | $154.3K |
| Quadrature Capital Ltd | 39,891 | $92.9K |
| Renaissance Technologies LLC | 22,200 | $51.9K |
| D. E. Shaw & Co., Inc. | 19,370 | $45.3K |
| Redwood Wealth Management Group, LLC | 30 | $70 |
Not filed for Q3 2024 yet (1)
Institutions that held Akoya Biosciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,501,887 | $3.51M |